Phyllis Gotlib Sells 3,573 Shares of American Well (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL) insider Phyllis Gotlib sold 3,573 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $11.80, for a total value of $42,161.40. Following the sale, the insider directly owned 149,181 shares of the company’s stock, valued at $1,760,335.80. This represents a 2.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Phyllis Gotlib also recently made the following trade(s):

• On Wednesday, July 1st, Phyllis Gotlib sold 6,677 shares of American Well stock. The shares were sold at an average price of $9.33, for a total value of $62,296.41.

American Well Stock Down 2.0%

AMWL stock opened at $12.99 on Friday. American Well Corporation has a twelve month low of $3.71 and a twelve month high of $14.19. The firm has a market cap of $214.98 million, a price-to-earnings ratio of -2.72 and a beta of 1.71. The business’s fifty day simple moving average is $11.41 and its two-hundred day simple moving average is $8.40.

American Well (NYSE:AMWL) last issued its earnings results on Tuesday, August 4th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.86) by $0.27. The firm had revenue of $52.05 million during the quarter, compared to analyst estimates of $49.87 million. American Well had a negative net margin of 35.75% and a negative return on equity of 30.12%. Research analysts expect that American Well Corporation will post -2.56 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of American Well in a research note on Friday, July 17th. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Wednesday, August 5th. Truist Financial set a $12.00 target price on shares of American Well and gave the company a “hold” rating in a research report on Thursday, August 13th. Finally, Wells Fargo & Company boosted their price target on shares of American Well from $9.00 to $16.00 and gave the company an “overweight” rating in a report on Friday, July 17th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $9.50.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in AMWL. Senvest Management LLC lifted its stake in shares of American Well by 213.3% during the 1st quarter. Senvest Management LLC now owns 1,136,558 shares of the company’s stock worth $5,978,000 after purchasing an additional 773,834 shares during the last quarter. Monaco Asset Management SAM purchased a new position in American Well in the fourth quarter valued at about $338,000. Squarepoint Ops LLC grew its stake in American Well by 74.5% in the fourth quarter. Squarepoint Ops LLC now owns 115,061 shares of the company’s stock valued at $565,000 after purchasing an additional 49,135 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in American Well by 280.6% in the first quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock worth $510,000 after purchasing an additional 47,745 shares in the last quarter. Finally, Jane Street Group LLC lifted its position in shares of American Well by 232.9% during the first quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock valued at $505,000 after buying an additional 44,852 shares during the last quarter. 56.05% of the stock is currently owned by hedge funds and other institutional investors.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company’s core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.